145 related articles for article (PubMed ID: 35916204)
1. LncRNA UBE2R2-AS1, as prognostic marker, promotes cell proliferation and EMT in prostate cancer.
Wang F; Zhao M; Jiang Y; Xia S; Sun D; Zhou D; Dong Z
Histol Histopathol; 2023 Jun; 38(6):637-645. PubMed ID: 35916204
[TBL] [Abstract][Full Text] [Related]
2. NUBE2R2-AS1 as Prognostic Marker, Promotes Cell Migration and Invasion in Non-Small Cell Lung Cancer by Modulating Epithelial-Mesenchymal Transition Process.
Liu X; Liao B; Wang L; Lu L; Yao W; Chen M
Ann Clin Lab Sci; 2022 May; 52(3):462-469. PubMed ID: 35777800
[TBL] [Abstract][Full Text] [Related]
3. LncRNA SSTR5-AS1 as a Prognostic Marker Promotes Cell Proliferation and Epithelial-to-Mesenchymal Transition in Prostate Cancer.
Yuan S; Bi J; Zhang Y
Crit Rev Eukaryot Gene Expr; 2023; 33(2):1-12. PubMed ID: 36734853
[TBL] [Abstract][Full Text] [Related]
4. Long noncoding RNA ABHD11-AS1 predicts the prognosis of pancreatic cancer patients and serves as a promoter by activating the PI3K-AKT pathway.
Qiao X; Lv SX; Qiao Y; Li QP; Ye B; Wang CC; Miao L
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8630-8639. PubMed ID: 30575903
[TBL] [Abstract][Full Text] [Related]
5. UBE2R2-AS1 Inhibits Xenograft Growth in Nude Mice and Correlates with a Positive Prognosis in Glioma.
Xu W; Che DD; Chen L; Lv SQ; Su J; Tan J; Liu Q; Pan YW
J Mol Neurosci; 2021 Aug; 71(8):1605-1613. PubMed ID: 33528791
[TBL] [Abstract][Full Text] [Related]
6. LncRNA ADAMTS9-AS1 knockdown restricts cell proliferation and EMT in non-small cell lung cancer.
Li Z; Yue G; Zhang T; Wu J; Tian X
Histol Histopathol; 2021 Oct; 36(10):1063-1072. PubMed ID: 34085704
[TBL] [Abstract][Full Text] [Related]
7. LMCD1-AS1 Facilitates Cell Proliferation and EMT by Sponging miR-873-3p in Cervical Cancer.
Liang M; Li Y; Chen C
Crit Rev Eukaryot Gene Expr; 2023; 33(2):13-25. PubMed ID: 36734854
[TBL] [Abstract][Full Text] [Related]
8. Upregulated expression of MNX1-AS1 long noncoding RNA predicts poor prognosis in gastric cancer.
Zhang W; Huang L; Lu X; Wang K; Ning X; Liu Z
Bosn J Basic Med Sci; 2019 May; 19(2):164-171. PubMed ID: 30821221
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of AR-regulated lncRNA TMPO-AS1 correlates with tumor progression and poor prognosis in prostate cancer.
Huang W; Su X; Yan W; Kong Z; Wang D; Huang Y; Zhai Q; Zhang X; Wu H; Li Y; Li T; Wan X
Prostate; 2018 Dec; 78(16):1248-1261. PubMed ID: 30105831
[TBL] [Abstract][Full Text] [Related]
10. LncRNA PSMB8-AS1 contributes to pancreatic cancer progression via modulating miR-382-3p/STAT1/PD-L1 axis.
Zhang H; Zhu C; He Z; Chen S; Li L; Sun C
J Exp Clin Cancer Res; 2020 Sep; 39(1):179. PubMed ID: 32891166
[TBL] [Abstract][Full Text] [Related]
11. LncUBE2R2-AS1 acts as a microRNA sponge of miR-302b to promote HCC progression via activation EGFR-PI3K-AKT signaling pathway.
Wu Z; Wei ZH; Chen SH
Cell Cycle; 2020 Oct; 19(19):2426-2435. PubMed ID: 32835579
[TBL] [Abstract][Full Text] [Related]
12. Long noncoding AGAP2-AS1 is activated by SP1 and promotes cell proliferation and invasion in gastric cancer.
Qi F; Liu X; Wu H; Yu X; Wei C; Huang X; Ji G; Nie F; Wang K
J Hematol Oncol; 2017 Feb; 10(1):48. PubMed ID: 28209205
[TBL] [Abstract][Full Text] [Related]
13. The lncRNA
Liu C; Li H; Yin Q
Open Med (Wars); 2020; 15(1):1184-1192. PubMed ID: 33336075
[TBL] [Abstract][Full Text] [Related]
14.
Luo Y; Tao H; Jin L; Xiang W; Guo W
Cancer Biother Radiopharm; 2020 Feb; 35(1):58-65. PubMed ID: 31724892
[No Abstract] [Full Text] [Related]
15. Knockdown of long non-coding RNA VIM-AS1 inhibits glioma cell proliferation and migration, and increases the cell apoptosis via modulation of WEE1 targeted by miR-105-5p.
Suo ST; Gong P; Peng XJ; Niu D; Guo YT
Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):6834-6847. PubMed ID: 32633376
[TBL] [Abstract][Full Text] [Related]
16. LncRNA FAM83A-AS1 promotes epithelial-mesenchymal transition of pancreatic cancer cells via Hippo pathway.
Wang H; Ding Y; Zhu Q; Yu Z; Wang Q; Gong A; Xu M
Cell Cycle; 2023 Jun; 22(12):1514-1527. PubMed ID: 37245082
[TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA PRRT3-AS1 silencing inhibits prostate cancer cell proliferation and promotes apoptosis and autophagy.
Fan L; Li H; Wang W
Exp Physiol; 2020 May; 105(5):793-808. PubMed ID: 32086850
[TBL] [Abstract][Full Text] [Related]
18. The Long Noncoding RNA LOXL1-AS1 Promotes the Proliferation, Migration, and Invasion in Hepatocellular Carcinoma.
Liu J; Zhai C; Liu D; Liu J
Anal Cell Pathol (Amst); 2020; 2020():4182092. PubMed ID: 33381389
[TBL] [Abstract][Full Text] [Related]
19. A Long Noncoding RNA ZEB1-AS1 Promotes Tumorigenesis and Predicts Poor Prognosis in Glioma.
Lv QL; Hu L; Chen SH; Sun B; Fu ML; Qin CZ; Qu Q; Wang GH; He CJ; Zhou HH
Int J Mol Sci; 2016 Aug; 17(9):. PubMed ID: 27589728
[TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA VIM-AS1 promotes prostate cancer growth and invasion by regulating epithelial-mesenchymal transition.
Zhang Y; Zhang J; Liang S; Lang G; Liu G; Liu P; Deng X
J BUON; 2019; 24(5):2090-2098. PubMed ID: 31786880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
